Nigel is a Partner in the Corporate department. With over 25 years' experience advising clients on M&A including public takeovers (with extensive experience in competitive and hostile situations), stock exchange matters and equity capital markets transactions.
He is valued by his wide range of clients for providing commercial, pragmatic and sound business advice. He is widely viewed as a trusted adviser to the boards of many UK and international listed companies, financial institutions and investors.
His practice spans a wide range of sectors including life sciences, betting and gaming, real estate, logistics, industrials and consumer businesses. He has advised on several global and UK "firsts."
Key experience
- Advised Marriott International Inc. on its public offer for Elegant Resorts plc.
- Advised Hikma Pharmaceuticals plc on numerous acquisitions and fundraisings.
- Advised Towers Watson on its $18bn merger of equals with Willis Group.
- Advised Amryt Pharmaceuticals plc on its acquisition of Aegerion out of chapter 11 and the associated relisting of the enlarged group on AIM.
- Advised Avnet on its £868m competitive offer for Premier Farnell plc.
- Advised GE Healthcare on numerous life sciences investments.
- Advised Terra Firma on the £921m sale of Odeon and UCI Cinemas.
- Advised UPS on its acquisition of Marken, a provider of supply chain solutions to the life sciences industry.
- Advised on the London IPO of Forterra plc.
- Advised on a proposed £70bn public offer for AstraZeneca.
- Advised Kindred on its £200m public offer for 32 Red Limited.
Career History
Partner, Mishcon de Reya LLP
Partner, Baker Botts
Partner, Gibson, Dunn & Crutcher LLP
Partner, Ashurst
Southampton University, Law